angioedema

(redirected from Hereditary angioedema)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

angioedema

[‚an·jē·ō·i′dē·mə]
(medicine)
The development of giant hives beneath the surface of the skin, especially around the eyes and lips; usually due to an allergic response.
References in periodicals archive ?
- The approved drugs in the hereditary angioedema space target complement proteins, androgen receptors, follicle-stimulating hormone, gonadotropin-releasing hormone, progesterone receptor, bradykinin B2 receptor, and the kinin-kallikrein system.
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy.
Ressel, "Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency," JAMA Internal Medicine, vol.
Cabanas, "Management of hereditary angioedema in pregnant women: A review," International Journal of Women's Health, vol.
Short analytical review: the pathophysiology of hereditary angioedema. Clin Immunol 2005;114(1):3-9.
RUCONEST[R] (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg is an injectable medicine that is used to treat acute angioedema attacks in adult and adolescent patients with hereditary angioedema (HAE).
Icatibant for the treatment of hereditary angioedema. Ann Pharmacother 2013;47(l):49-55.
Dr Bruno Giannetti, MD PhD, chief operations officer of Pharming, said, 'hereditary angioedema patients in the US are currently facing a shortage of plasma-derived C1 inhibitor used to prevent attacks.
Pharmaceutical company Pharming Group NV (Euronext Amsterdam:PHARM) revealed on Monday that it has filed its supplemental Biologics License Application (BLA) with the US Food and Drug Administration (FDA) for RUCONEST for routine prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema (HAE).
Contract notice: fn motol - drugs used in hereditary angioedema.
Full browser ?